Anne Moreau

ORCID: 0000-0002-1750-5035
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lymphoma Diagnosis and Treatment
  • Viral-associated cancers and disorders
  • Chronic Lymphocytic Leukemia Research
  • Sarcoma Diagnosis and Treatment
  • Vasculitis and related conditions
  • Histiocytic Disorders and Treatments
  • Cytomegalovirus and herpesvirus research
  • Bladder and Urothelial Cancer Treatments
  • Respiratory Support and Mechanisms
  • Renal Transplantation Outcomes and Treatments
  • Mast cells and histamine
  • Colorectal and Anal Carcinomas
  • Adrenal Hormones and Disorders
  • Cell Adhesion Molecules Research
  • Mechanical Circulatory Support Devices
  • Bone Metabolism and Diseases
  • Eosinophilic Disorders and Syndromes
  • Polyomavirus and related diseases
  • Sarcoidosis and Beryllium Toxicity Research
  • Renal Diseases and Glomerulopathies
  • Otitis Media and Relapsing Polychondritis
  • Soft tissue tumor case studies
  • Cardiac Arrest and Resuscitation
  • Pituitary Gland Disorders and Treatments
  • Neuroblastoma Research and Treatments

University of Liège
2024

Nantes Université
1983-2023

Centre Hospitalier Universitaire de Lille
2017-2023

Centre Hospitalier Départemental Vendée
2023

Roche (France)
2023

Centre Hospitalier Universitaire de Nantes
1999-2022

Université de Lille
2017-2020

Hotel Dieu Hospital
1992-2018

Hôtel-Dieu de Paris
1997-2016

Hôpital Ambroise-Paré
2016

Long-term allograft survival generally requires lifelong immunosuppression (IS). Rarely, recipients display spontaneous "operational tolerance" with stable graft function in the absence of IS. The lack biological markers this phenomenon precludes identification potentially tolerant patients which IS could be tapered and hinders development new tolerance-inducing strategies. objective study was to identify minimally invasive blood biomarkers for operational tolerance use these determine...

10.1073/pnas.0705834104 article EN Proceedings of the National Academy of Sciences 2007-09-15

Background Since 2010, nationwide networks of reference centers for sarcomas (RREPS/NETSARC/RESOS) collected and prospectively reviewed all cases connective tumors intermediate malignancy (TIM) in France. Methods The incidence sarcoma or TIM (2013–2016) was measured using the 2013 WHO classification confirmed by a second independent review expert pathologists. Simple clinical characteristics, yearly variations correlation with published trials are presented analyzed. Results Over 150...

10.1371/journal.pone.0246958 article EN cc-by PLoS ONE 2021-02-25

Abstract Interleukin‐34 (IL‐34) is a newly discovered regulator of myeloid lineage differentiation, proliferation, and survival, acting via the macrophage‐colony stimulating factor receptor (M‐CSF receptor, c‐fms). M‐CSF, main ligand for c‐fms, required osteoclastogenesis has been already identified as critical contributor pathogenesis giant cell tumours bone (GCTs), rich in osteoclasts. According to key role M‐CSF GCTs, expression IL‐34 human GCTs was first assessed. Quantitative analysis...

10.1002/path.2684 article EN The Journal of Pathology 2010-01-08

Abstract RANK, RANK ligand (RANKL) and osteoprotegerin (OPG) are the key regulators of bone metabolism, both in normal pathological conditions. Previous data have demonstrated that human osteosarcoma biopsies express RANKL as well OPG, functional is expressed a murine cell line. As expression remains controversial, aim present study was to analyse its vitro lines, ex vivo using tissues, then determine functionality terms signal transduction pathways modulated by RANKL. RT‐PCR analysis...

10.1002/path.2140 article EN The Journal of Pathology 2007-02-26

Data regarding the incidence and outcome of renal involvement in patients with inflammatory myopathies (IM) remain scarce. We assessed causes acute kidney injury (AKI) chronic disease (CKD) 150 dermatomyositis, polymyositis, antisynthetase syndrome followed 3 French referral centers. Renal occurred 35 (23.3%) patients: AKI 16 (10.7%), CKD 31 (20.7%) patients. The main cause was drug or myoglobinuria-induced tubular necrosis. Male sex, cardiovascular risk factors, cardiac involvement, initial...

10.1097/md.0000000000000015 article EN cc-by-nc Medicine 2013-12-30

Giant cell tumors (GCTs) with high mobility group AT-Hook 2 ( HMGA2 )::nuclear receptor corepressor NCOR2 ) fusion are rare mesenchymal of controversial nosology, which have been anecdotally reported to respond CSFR1 inhibitors. Here, we performed a comprehensive study 6 GCTs HMGA2::NCOR2 and explored their relationship other giant cell-rich neoplasms. Tumors occurred in 4 females males ranging age from 17 32 years old (median 24). Three lesions originated subcutaneous soft tissue 3 bone....

10.1097/pas.0000000000002051 article EN The American Journal of Surgical Pathology 2023-05-12

Hodgkin's disease (HD) has seldom been reported after transplantation. Epstein-Barr virus (EBV) is present in about 50% of Reed-Sternberg cells HD developing immunocompetent individuals, but more frequently found acquired immune deficiency syndrome patients. We report 7 cases that occurred transplant recipients. Clinical and pathological data studies EBV reveal specific features Six patients received kidney transplants 1 patient combined pancreas Immunosuppressive therapy consisted...

10.1097/00007890-199601150-00015 article EN Transplantation 1996-01-01

The outcomes of patients admitted to the intensive care unit (ICU) for acute manifestation small-vessel vasculitis are poorly reported. aim present study was determine mortality rate and prognostic factors ICU vasculitis.This retrospective, multicenter conducted from January 2001 December 2014 in 20 ICUs France. Patients were identified computerized registers each hospital using International Classification Diseases, Ninth Revision (ICD-9). Inclusion criteria (1) known or highly suspected...

10.1186/s13054-016-1189-5 article EN cc-by Critical Care 2016-01-26

It is unclear whether influenza infection and associated co-infection are with patient-important outcomes in critically ill immunocompromised patients acute respiratory failure. Preplanned secondary analysis of EFRAIM, a prospective cohort study 68 hospitals 16 countries. We included 1611 aged 18 years or older non-AIDS-related immunocompromise, who were admitted to the ICU hypoxemic The main exposure interest was status. primary outcome all-cause hospital mortality, length stay (LOS) 90-day...

10.1186/s13054-019-2425-6 article EN cc-by Critical Care 2019-05-02

A case of fatal Epstein–Barr virus infection in a previously healthy girl who was first found to have severe infectious mononucleosis with spontaneous recovery is reported. Because an abnormal immune response the persisted, disease relapsed, manifesting cutaneous and pulmonary lesions associated hemophagocytic syndrome responsible for death. Pathologic findings were characterized by polymorphous atypical lymphoid infiltrate, prominent necrosis, histiocytic hyperplasia. Lymphoid cells...

10.1093/ajcp/98.3.324 article EN American Journal of Clinical Pathology 1992-09-01

Targeted monoclonal antibody (mAb) therapies show great promise for the treatment of transplant rejection and autoimmune diseases by inducing more specific immunomodulatory effects than broadly immunosuppressive drugs routinely used. We recently described therapeutic advantage targeting CD45RC, expressed at high levels conventional T (Tconv) cells (CD45RChi), their precursors, terminally differentiated (TEMRA) cells, but not regulatory (Tregs; CD45RClo/-). demonstrated efficacy anti-CD45RC...

10.1172/jci156507 article EN cc-by Journal of Clinical Investigation 2022-02-15

No gold standard exists for histopathological diagnosis of a prosthetic joint infection (PJI). The historical criterion considers the presence neutrophil infiltration upon examination periprosthetic tissue. Morawietz et al. proposed classification membranes (Morawietz al., Clin Pathol 59:591-597, 2006, https://doi.org/10.1136/jcp.2005.027458) and more recently described with new cutoff value 23 neutrophils in 10 high-power fields Histopathology 54:847-853, 2009....

10.1128/jcm.00536-18 article EN Journal of Clinical Microbiology 2018-07-03
Alexandre Demoule Massimo Antonelli Peter Schellongowski Peter Pickkers Márcio Soares and 95 more Tine Sylvest Meyhoff Jordi Rello Philippe R. Bauer Andry van de Louw Virgine Lemiale David Grimaldi Ignacio Martín‐Loeches Martin Balík Sangeeta Mehta Achille Kouatchet Andreas Barratt‐Due Miia Valkonen Jean Reignier Victoria Metaxa Anne‐Sophie Moreau Gastón Burghi Djamel Mokart Julien Mayaux Michaël Darmon Élie Azoulay Karin Amrein Peter Schellongowski Thomas Staundinger Gottfried Heinz Gürkan Sengölge Christian Zauner Péter Jaksch Fabio Silvio Taccone David Grimaldi Anne Pascale Meert Dominique Benoît Ulysses V. A. Silva Ana Paula Pierre de Moraes Thiago Lishoa Márcio Soares Jorge I. Salluh William Viana Guilliana Moralez Thiago Domingos Corrêa Sangeeta Mehta U. Shah Thomas Karvunidis Balik Martin Katerina Russinova Anders Perner Tine Sylvest Meyhoff Jonas Nielsen Ramin Brandt Bukan Ann M. Moeller Lene Nielsen Achille Kouatchet Amélie Seguin Akli Chermak Nicolas Terzi Isabelle Vinatier Anne‐Sophie Moreau Florent Wallet Djamel Mokart Kada Klouche Laura Platon Benjamin Gaborit François Barbier Frédéric Pène Antoine Rabbat Alexandre Demoule Julien Mayaux Élie Azoulay Virginie Lemiale Martine Nyunga Christophe Girault Caroline Lemaître Élise Artaud-Macari Michaël Darmon Fabrice Bruneel Anne Moreau Miia Valkonen Anne Kuitunen Brian Marsh Mater Misericordia Ignacio Martín‐Loeches Aisling McMahon Gilda Cinnella Antonella Cotoia Ospedali Riuniti Massimo Antonelli Lucas Montini A. Man Precious Pearl Landburg Dennis Bergmans Peter Pickkers Pleun Hemelaar Thomas Kaufmann Andreas Barrat-Due Pål Klepstad Jordi Rello

10.1016/j.chest.2020.05.602 article EN publisher-specific-oa CHEST Journal 2020-06-20
Coming Soon ...